Joan Sweet
Papers
1
Total Citations
21
H-Index
1
About
Dr. Joan Sweet is a pioneering urologic oncologist whose work centers on advancing minimally invasive surgical techniques for testicular cancer. Her most impactful contribution is the development and refinement of robotic retroperitoneal lymph node dissection (R-RPLND), a complex procedure that reduces morbidity compared to traditional open surgery. Her landmark 2021 paper, "Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer," has garnered 21 citations and serves as a cornerstone reference for surgeons adopting this approach. Dr. Sweet’s research has demonstrated that R-RPLND is both safe and effective for primary and post-chemotherapy settings, expanding treatment options for patients with testicular germ cell tumors. Her work has been instrumental in standardizing robotic techniques, improving recovery times, and reducing complications. Beyond her publications, she is recognized for her leadership in surgical education and multidisciplinary care, shaping how testicular cancer is managed in the modern era. Dr. Sweet’s contributions continue to influence urologic oncology, offering patients less invasive yet equally curative surgical alternatives.
Research Focus
Key Achievements
Top Papers
- 1